CMV423, a potent and selective inhibitor of human herpesvirus 6 exerts its antiviral action through inhibition of cellular protein tyrosine kinase activity

Leen De Bolle; Graciela Andreï; Robert Snoeck; Alfons Van Lommel; Markus Otto; Anne Bousseau; Christine Le Roy; De Clercq Erik; Lieve Naesens

Back

CMV423, a potent and selective inhibitor of human herpesvirus 6 exerts its antiviral action through inhibition of cellular protein tyrosine kinase activity

Article 2003 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2003

Potent, selective and cell-mediated inhibition of human herpesvirus 6 at an early stage of viral replication by the non-nucleoside compound CMV423

Leen De Bolle, Graciela Andreï, Robert Snoeck, Ying Zhang, Alfons Van Lommel, Michaël Otto, Anne Bousseau, Christine Le Roy, De Clercq Erik, Lieve Naesens

Article1995

Antiviral activity of selected acyclic nucleoside analogues against human herpesvirus 6

D. Reymen, Lieve Naesens, Jan Balzarini, Antonı́n Holý, Hana Dvořáková, De Clercq Erik

Article1991

Mechanism of antiviral and cytotoxic action of (+/-)-6' beta-fluoroaristeromycin, a potent inhibitor of S-adenosylhomocysteine hydrolase.

Marina Cools, Jan Balzarini, De Clercq Erik

Article1997

Selective Activity of Various Nucleoside and Nucleotide Analogues against Human Herpesvirus 6 and 7

K. TAKAHASHI, Michio Suzuki, Y Iwata, Shirô Shigeta, K Yamanishi, De Clercq Erik

Article1996

New Neplanocin Analogues. 6. Synthesis and Potent Antiviral Activity of 6‘-Homoneplanocin A

Satoshi Shuto, Takumi Obara, Yasuyoshi Saito, Graciela Andreï, Robert Snoeck, De Clercq Erik, Akira Matsuda